D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
AT&T
T
|
$518M |
| 2 |
Booking.com
BKNG
|
$474M |
| 3 |
Qualcomm
QCOM
|
$436M |
| 4 |
Chevron
CVX
|
$270M |
| 5 |
Meta Platforms (Facebook)
META
|
$203M |
Top Sells
| 1 |
Apple
AAPL
|
$990M |
| 2 |
Netflix
NFLX
|
$315M |
| 3 |
Johnson & Johnson
JNJ
|
$254M |
| 4 |
McDonald's
MCD
|
$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$223M |
Sector Composition
| 1 | Technology | 18.97% |
| 2 | Consumer Discretionary | 16.19% |
| 3 | Healthcare | 13.32% |
| 4 | Financials | 11.3% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Healthpeak Properties
DOC
$12.8B
| $77.1M | 0.09% |
2,928,925
-711,251
| -20% | -$18.7M |
|
202
LKQ Corp
LKQ
$8.33B
| $76.7M | 0.09% |
2,422,033
-481,596
| -17% | -$15.3M |
|
203
Southwest Airlines
LUV
$16.5B
| $76.5M | 0.09% |
1,224,221
-202,543
| -14% | -$12.6M |
|
|
204
Johnson & Johnson
JNJ
$430B
| $76.3M | 0.09% |
552,123
-1,838,726
| -77% | -$254M |
|
205
Best Buy
BBY
$16.1B
| $75.1M | 0.09% |
945,774
+12,547
| +1% | +$996K |
|
|
ENDP
206
DELISTED
Endo International plc
ENDP
| $74.5M | 0.09% |
4,424,035
+105,139
| +2% | +$1.77M |
|
207
Bruker
BRKR
$4.68B
| $73.4M | 0.09% |
2,195,050
+159,844
| +8% | +$5.35M |
|
|
ALXN
208
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $72.8M | 0.09% |
524,006
-67,885
| -11% | -$9.44M |
|
209
Hologic
HOLX
$14.8B
| $72.7M | 0.09% |
1,774,615
-189,777
| -10% | -$7.78M |
|
210
Humana
HUM
$37B
| $72.2M | 0.09% |
213,224
-35,947
| -14% | -$12.2M |
|
211
Prudential Financial
PRU
$37.2B
| $71.6M | 0.09% |
707,003
+213
| +0% | +$21.6K |
|
|
ANDV
212
DELISTED
Andeavor
ANDV
| $71.6M | 0.09% |
466,370
-406,584
| -47% | -$62.4M |
|
213
Cleveland-Cliffs
CLF
$5.63B
| $71M | 0.09% |
5,611,560
+4,899,081
| +688% | +$62M |
|
214
Goldman Sachs
GS
$223B
| $69.6M | 0.08% |
310,552
-608,198
| -66% | -$136M |
|
|
CDK
215
DELISTED
CDK Global, Inc.
CDK
| $69.6M | 0.08% |
1,111,972
+406,638
| +58% | +$25.4M |
|
216
Norfolk Southern
NSC
$62.3B
| $69.1M | 0.08% |
382,765
-37,159
| -9% | -$6.71M |
|
|
VSM
217
DELISTED
Versum Materials, Inc.
VSM
| $68.8M | 0.08% |
1,910,413
+117,402
| +7% | +$4.23M |
|
218
Ametek
AME
$43.3B
| $68.4M | 0.08% |
864,465
-219,913
| -20% | -$17.4M |
|
|
SINA
219
DELISTED
Sina Corp
SINA
| $68.3M | 0.08% |
982,694
+824,591
| +522% | +$57.3M |
|
220
Fastenal
FAST
$55.1B
| $68.1M | 0.08% |
4,693,052
+3,878,768
| +476% | +$56.3M |
|
221
State Street
STT
$32B
| $66.7M | 0.08% |
796,710
+516,548
| +184% | +$43.3M |
|
222
Under Armour
UAA
$2.2B
| $66.4M | 0.08% |
3,130,439
+539,790
| +21% | +$11.5M |
|
223
Owens Corning
OC
$13B
| $66.4M | 0.08% |
1,223,998
+82,037
| +7% | +$4.45M |
|
224
US Foods
USFD
$17.5B
| $66M | 0.08% |
2,139,856
+187,378
| +10% | +$5.77M |
|
225
VF Corp
VFC
$5.86B
| $65.6M | 0.08% |
745,712
+376,301
| +102% | +$33.1M |
|